Survey Results Reveal Best Practices in Life Science Revenue Management

Over the last five years, Computer Sciences Corporation and Model N have teamed up to benchmark the Revenue Management business practices of Life Science companies. The annual survey examines the state of pricing, contracting, settlements, and regulatory compliance business processes and identifies emerging best practices among responding companies.

Participants in the 2007 surveys included a healthy mix of market segments: Fortune 100 medical technology and pharmaceutical companies; mid-market and emerging biotech and pharmaceutical organizations; manufacturers and distributors; and generic and branded companies.

An analysis of this year’s benchmark surveys confirms the importance of effective revenue management and identifies significant opportunities to improve the impact and effectiveness of revenue management to reduce revenue leakage and regulatory compliance risk.

To learn more about the 2007 survey results, choose one of the following links:

Web Seminar Recording

Survey Report for Medical Technology Companies (pdf)

Survey Report for Pharmaceutical and Biotech Companies (pdf)

 

 

"The fact that we continue to see the number and complexity of life science contracts increase every year is indicative of the highly competitive nature of the industry and the need for health care payers/providers to aggressively manage costs. We believe that this trend could lead to a ‘mass customization’ of contracting, with companies managing large volumes of contracts at the individual institution and provider levels. In such an environment, organizations will need to change their approach from contract management to holistic revenue management.”

   - Robert Matsuk, Pricing and Contracting Solution Director, CSC Global Healthcare Solutions

 

 

Contact Model N